Selma Blair recounted a date from the past with Robbie Williams during an appearance on The Drew Barrymore Show. She explained that they were at her house and he opened her refrigerator.

Selma Blair discussed her heartbreaking MS relapse during a candid chat on Tuesday's Drew Barrymore Show. The actress, 52, ...

Europe’s CHMP top scientific committee gave a positive opinion for approval to cladribine, with the proposed trade name Mavenclad, for relapsing forms of MS with high disease activity.

Cladribine (Mavenclad) is a pill that you take for a total of 16 or 20 days over the course of 2 years. You’ll have treatment for 2 weeks per year, with each session lasting 4 or 5 days.

Gilenya was first approved in 2010 and has been a big brand for Novartis, although it is facing strong competition from newer drugs such as Roche's Ocrevus (ocrelizumab), Merck KGaA's Mavenclad ...

Mavenclad is taken by mouth in two yearly treatment courses. Each yearly treatment course consists of two cycles (lasting four or five days) that are about a month apart. Intravenous infusion of ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

A second medical use for cladribine was subsequently found, however, for treating multiple sclerosis and in 2017 a product called Mavenclad was granted marketing authorisation for that purpose. Under ...

Mavenclad is taken by mouth in two yearly treatment courses. Each yearly treatment course consists of two cycles (lasting four or five days) that are about a month apart. Gilenya, Tascenso ODT ...

Mavenclad (cladribine) is for highly active relapsing forms of MS. The dosage schedule is unusual, with short periods of taking pills spread out over two years. This drug temporarily reduces your ...